Related references
Note: Only part of the references are listed.Targeting CDK2 in cancer: challenges and opportunities for therapy
Solomon Tadesse et al.
DRUG DISCOVERY TODAY (2020)
Expression of Cyclin E/Cdk2/p27Kip1 in Growth Hormone Adenomas
Wei Dong et al.
WORLD NEUROSURGERY (2019)
Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
Daniel J. Wood et al.
CELL CHEMICAL BIOLOGY (2019)
Interaction entropy for computational alanine scanning in protein-protein binding
Linqiong Qiu et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2018)
Computational Alanine Scanning with Interaction Entropy for Protein-Ligand Binding Free Energies
Xiao Liu et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Residue-specific free energy analysis in ligand bindings to JAK2
Yifan Zhou et al.
MOLECULAR PHYSICS (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
CDK4/6 blockade in breast cancer: current experience and future perspectives
Dimitrios Zardavas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Efficient Approximation of Ligand Rotational and Translational Entropy Changes upon Binding for Use in MM-PBSA Calculations
Ido Y. Ben-Shalom et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Interaction Entropy for Computational Alanine Scanning
Yuna Yan et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Interaction Entropy: A New Paradigm for Highly Efficient and Reliable Computation of Protein-Ligand Binding Free Energy
Lili Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Predicting Binding Free Energy Change Caused by Point Mutations with Knowledge-Modified MM/PBSA Method
Marharyta Petukh et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
New roles for cyclin-dependent kinases in T cell biology: linking cell division and differentiation
Andrew D. Wells et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Foxp3 Protein Stability Is Regulated by Cyclin-dependent Kinase 2
Peter A. Morawski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
Ernst Schonbrunn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
An overview of the Amber biomolecular simulation package
Romelia Salomon-Ferrer et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2013)
Cyclin-Dependent Kinase 2 Controls Peripheral Immune Tolerance
Neelanjana Chunder et al.
JOURNAL OF IMMUNOLOGY (2012)
Cyclin-dependent kinase inhibitors move into Phase III
Malini Guha
NATURE REVIEWS DRUG DISCOVERY (2012)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
Tingjun Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Cell cycle proteins in epithelial cell differentiation Implications for breast cancer
C. Elizabeth Caldon et al.
CELL CYCLE (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2
Shuai Chen et al.
NATURE CELL BIOLOGY (2010)
Protein kinase inhibitors: contributions from structure to clinical compounds
Louise N. Johnson
QUARTERLY REVIEWS OF BIOPHYSICS (2009)
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
The cyclin-dependent kinase inhibitor seliciclib (Rroscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis
Steven R. Whittaker et al.
CELL CYCLE (2007)
Cyclin-dependent kinase pathways as targets for cancer treatment
GI Shapiro
JOURNAL OF CLINICAL ONCOLOGY (2006)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF
JY Du et al.
CANCER CELL (2004)
Exploring protein native states and large-scale conformational changes with a modified generalized born model
A Onufriev et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Share Paper
